EFFECTIVENESS OF A CLINICAL DECISION SUPPORT SYSTEM INCORPORATING A VALIDATED QT INTERVAL PROLONGATION RISK SCORE FOR REDUCING THE RISK OF QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS

被引：1
|
作者：
Tisdale, James
Wroblewski, Heather
Kingery, Joanna
Overholser, Brian
Trujillo, Tate N.
Kovacs, Richard
机构：
[1] Purdue Univ, Indianapolis, IN USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)61800-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E1799 / E1799
页数：1
相关论文
共 50 条
  • [1] Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients
    Tisdale, James E.
    Jaynes, Heather A.
    Kingery, Joanna R.
    Overholser, Brian R.
    Mourad, Noha A.
    Trujillo, Tate N.
    Kovacs, Richard J.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (03): : 381 - 390
  • [2] A RISK SCORE TO PREDICT QT INTERVAL PROLONGATION IN HOSPITALIZED PATIENTS
    Tisdale, James
    Wroblewski, Heather A.
    Kingery, Joanna R.
    Trujillo, Tate N.
    Overholser, Brian R.
    Kovacs, Richard J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E112 - E112
  • [3] Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients (vol 7, pg 381, 2014)
    Tisdale
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (06): : 981 - 981
  • [4] Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
    Tisdale, James E.
    Jaynes, Heather A.
    Kingery, Joanna R.
    Mourad, Noha A.
    Trujillo, Tate N.
    Overholser, Brian R.
    Kovacs, Richard J.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (04): : 479 - 487
  • [5] MEASUREMENT OF THE QT INTERVAL AND THE RISK ASSOCIATED WITH QT(C) INTERVAL PROLONGATION - A REVIEW
    MOSS, AJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (06): : B23 - B25
  • [6] Multifactorial QT Interval Prolongation: The Risk of Polypharmacy
    Digby, G.
    Perez Riera, A. R.
    Barros, R. B.
    de Sousa Belem, L.
    Fong, C.
    Methot, M.
    Femenia, F.
    Baranchuk, A.
    [J]. NEW HORIZONS IN CARDIOVASCULAR DISEASES, 2010, : 241 - 244
  • [7] Reconciling the risk of QT interval prolongation in antidepressants
    McKean, Alastair J.
    Sola, Christopher L.
    Galardy, Christine
    Kung, Simon
    Lineberry, Timothy W.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (03) : 329 - 330
  • [8] The preclinical assessment of the risk for QT interval prolongation
    Champeroux, P
    Martel, E
    Vannier, C
    Blanc, V
    Leguennec, JY
    Fowler, J
    Richard, S
    [J]. THERAPIE, 2000, 55 (01): : 101 - 109
  • [9] MULTIFACTORIAL QT INTERVAL PROLONGATION: THE RISK OF POLYPHARMACY
    Digby, G. C.
    Riera, A. R.
    Barros, R. B.
    Belem, L. S.
    Fong, C.
    Methot, M.
    Femenia, F.
    Baranchuk, A. M.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 132D - 132D
  • [10] Risk factors of QT interval prolongation in Japanese patients with schizophrenia
    Ozeki, Y.
    Aoki, T.
    Fujii, K.
    Kurimoto, N.
    Takahashi, J.
    Ishida, N.
    Narita, M.
    Yamada, N.
    Saitoh, O.
    Horie, M.
    Kunigi, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 149 - 149
12345